The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.
CHEST guidelines on biologic management in severe adult asthma offers recommendations on choosing and switching among biologic therapies.
Advice on recommended inhaler treatment regimens for asthma, and the shift to SABA-free care, and how to embed these regimens in practice ...
Objective Systemic corticosteroids for 5–7 days are standard care for asthma exacerbations, but the optimal duration and ...
Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...
If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...
Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.
HealthDay News — For adults with oral corticosteroid (OCS)-dependent severe uncontrolled asthma, tezepelumab can help to reduce OCS use, according to a study published online November 26 in The Lancet ...
For patients with food allergies and their families, shopping is not the only thing stressing them out during the holiday ...
The 2025 AAO‐HNSF adult sinusitis guideline, an update of the 2015 guideline, offers evidence-based recommendations on rhinosinusitis management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback